Rita Trozzi

5PUBLICATIONS
23CO-AUTHORS
HaematologyPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Gene expression (incl. microarray and other genome-wide approaches)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Mar 14, 2025
Reply to: Reflections on the HORSE Trial: Hyperthermic Intraperitoneal Chemotherapy, BRCA Status, and Clinical Implications.

Anna Fagotti, Rita Trozzi, Diana Giannarelli

|Jan 26, 2025
POLE mutations in endometrial carcinoma: Clinical and genomic landscape from a large prospective single-center cohort.

Camilla Nero, Rita Trozzi, Federica Persiani

|Nov 21, 2024
Hyperthermic Intraperitoneal Chemotherapy in Platinum-Sensitive Recurrent Ovarian Cancer: A Randomized Trial on Survival Evaluation (HORSE; MITO-18).

Anna Fagotti, Barbara Costantini, Francesco Fanfani

|Jun 03, 2024
Identification of a False-positive Multiplex Ligationdependent Probe Amplification Result in BRCA1 Using a Copy Number Variation Algorithm Under Development for a Commercial Next-Generation Sequencing-based Homologous Recombination Deficiency Assay.

Paola Concolino, Elisa De Paolis, Martina Rinelli

|May 09, 2024
An open-label, single-arm, prospective, multi-center, tandem two-stage designed phase II study to evaluate the efficacy of fulvestrant in women with recurrent/metastatic estrogen receptor-positive gynecological malignancies (FUCHSia study).

Rita Trozzi, Sandra Tuyaerts, Daniela Annibali

Pageof 1

Frequent Collaborators

4 joint publications

Giovanni Scambia

2 joint publications

Diana Giannarelli

2 joint publications

Simona Duranti

2 joint publications

Luciano Giacò